81 results
8-K
EX-99.1
IMNN
Imunon Inc
28 Mar 24
IMUNON Reports 2023 Financial Results and Provides Business Update
8:05am
, with the hazard ratio nearing the study objective. Preliminary OS data followed a similar trend, showing an approximate nine-month improvement in the treatment … progression in the treatment arm of approximately three months compared with the control arm, with the hazard ratio nearing the study objective. Preliminary OS
8-K
EX-10.1
lpmvkm u6
11 Dec 23
Departure of Directors or Certain Officers
8:35am
8-K
EX-99.1
vp4df9r50n
11 Dec 23
Departure of Directors or Certain Officers
8:35am
8-K
4yk39lhc 9he
11 Dec 23
Departure of Directors or Certain Officers
8:35am
8-K
EX-99.1
sjuwcvvmk
14 Nov 23
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.1
5ylidow 7kyv
15 Aug 22
Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
28wofmnj7 m6be9un
16 May 22
Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update
8:00am